|
|
|
Insider
Information: |
Walbert Timothy P |
Relationship: |
Director |
City: |
Waukegan |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
131,514 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,120,342 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
131,514 |
|
|
Total
Value |
$3,120,342 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Horizon Pharma, Inc. |
HZNP |
Chairman, President an... |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
XOMA Corporation |
XOMA |
Director |
2016-07-21 |
129,314 |
2012-11-13 |
0 |
Premium* |
|
Egalet Corp |
EGLT |
Director |
2020-05-20 |
0 |
|
0 |
Premium* |
|
Sucampo Pharmaceuticals, Inc. |
SCMP |
Director |
2018-02-13 |
0 |
2016-06-02 |
0 |
Premium* |
|
Sagimet Biosciences Inc. |
SGMT |
Director |
2024-04-01 |
2,200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
160 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-05-20 |
4 |
AS |
$90.00 |
$2,250,000 |
D/D |
(25,000) |
460,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-01-14 |
4 |
AS |
$90.02 |
$2,250,413 |
D/D |
(25,000) |
674,222 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2021-06-01 |
4 |
AS |
$91.00 |
$2,296,204 |
D/D |
(25,000) |
875,887 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-06-03 |
4 |
AS |
$92.08 |
$2,308,468 |
D/D |
(25,000) |
435,826 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-05-31 |
4 |
AS |
$92.04 |
$2,311,980 |
D/D |
(25,000) |
435,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-02-25 |
4 |
AS |
$92.51 |
$2,312,663 |
D/D |
(25,000) |
585,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2021-06-30 |
4 |
AS |
$93.80 |
$2,346,380 |
D/D |
(25,000) |
850,887 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2021-04-30 |
4 |
AS |
$94.15 |
$2,374,413 |
D/D |
(25,000) |
899,838 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-05-02 |
4 |
AS |
$95.38 |
$2,401,006 |
D/D |
(25,000) |
460,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-02-11 |
4 |
AS |
$97.32 |
$2,435,242 |
D/D |
(25,000) |
585,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2021-03-01 |
4 |
AS |
$91.29 |
$2,464,137 |
D/D |
(26,975) |
924,838 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-03-11 |
4 |
AS |
$100.77 |
$2,523,314 |
D/D |
(25,000) |
535,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2021-07-30 |
4 |
AS |
$101.65 |
$2,543,489 |
D/D |
(25,000) |
840,288 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-04-22 |
4 |
AS |
$106.10 |
$2,664,632 |
D/D |
(25,000) |
485,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-03-25 |
4 |
AS |
$109.37 |
$2,734,340 |
D/D |
(25,000) |
535,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-04-08 |
4 |
AS |
$111.70 |
$2,809,521 |
D/D |
(25,000) |
485,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2018-11-14 |
4 |
OE |
$4.96 |
$2,906,049 |
D/D |
408,347 |
954,417 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2021-11-01 |
4 |
AS |
$117.31 |
$2,962,327 |
D/D |
(25,000) |
554,482 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2020-01-06 |
4 |
AS |
$35.57 |
$3,019,395 |
D/D |
(84,886) |
903,309 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2020-02-21 |
4 |
AS |
$35.23 |
$3,306,829 |
D/D |
(93,864) |
847,743 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-02-28 |
4 |
AS |
$90.41 |
$4,551,848 |
D/D |
(50,000) |
535,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2022-03-30 |
4 |
AS |
$104.61 |
$5,262,787 |
D/D |
(50,000) |
485,549 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2023-01-01 |
4 |
D |
$113.80 |
$5,276,337 |
D/D |
(46,365) |
493,959 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2021-09-30 |
4 |
AS |
$109.96 |
$5,515,140 |
D/D |
(50,000) |
579,482 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
|
2020-01-05 |
4 |
D |
$36.10 |
$6,076,316 |
D/D |
(168,319) |
988,195 |
0 |
- |
|
160 Records found
|
|
Page 6 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|